Get started
Award

MOP/LAS chimeric vaccine against Lassa fever

Funding type: research
Funder scheme: R01
Start date: 2003-12-01
End date: 2009-04-30
Institutions: University of Maryland, Baltimore, UNIVERSITY OF MARYLAND BALTIMORE
Field: Medicine
Funded outputs count: 20
Funder award ID: R01AI052367
OpenAlex ID: G6175433079
Improving the Breadth of the Host’s Immune Response to Lassa Virus
2018 · Juan Zapata, Sandra Medina-Moreno, et al. · Pathogens · 19
PDF
Vaccine platforms to control Lassa fever
2016 · Igor S. Lukashevich, Peter Pushko · Expert Review of Vaccines · 47
Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice
2014 · Irina Tretyakova, Brian Nickols, et al. · Virology · 35
PDF
Genetic Variation In Vitro and In Vivo of an Attenuated Lassa Vaccine Candidate
2013 · Juan C. Zapata, Marco Goicochea, et al. · Journal of Virology · 16
PDF
Transcriptome Analysis of Human Peripheral Blood Mononuclear Cells Exposed to Lassa Virus and to the Attenuated Mopeia/Lassa Reassortant 29 (ML29), a Vaccine Candidate
2013 · Juan Carlos Zapata, Ricardo Carrion, et al. · PLoS neglected tropical diseases · 37
PDF
An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity
2013 · Juan C Zapata, Bhawna Poonia, et al. · Virology Journal · 52
PDF
The search for animal models for Lassa fever vaccine development
2012 · Igor S Lukashevich · Expert Review of Vaccines · 51
Advanced Vaccine Candidates for Lassa Fever
2012 · Igor S. Lukashevich · Viruses · 69
PDF
Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model
2012 · Marco A. Goicochea, Juan C. Zapata, et al. · Vaccine · 41
Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers
2012 · Ricardo Carrion Jr, Peter Bredenbeek, et al. · Journal of Vaccines & Vaccination · 27
PDF
Geronto-formação : formação nas idades avançadas para a info-inclusão
2011 · Henrique Gil, Fausto Amaro · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Density Effects in Model Deformation Measurements on a NACA 0010 Profile in a Transonic Flow
2010 · Tania Kirmse, Anthony Gardner, et al. · elib (German Aerospace Center) · 4
Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates
2008 · Igor S. Lukashevich, Ricardo Carrion, et al. · Vaccine · 138
A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity
2007 · Ricardo Carrion, Jean L. Patterson, et al. · Vaccine · 102
Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses
2006 · Dmitry A. Moshkoff, Maria S. Salvato, et al. · Virus Genes · 33
A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins
2006 · Peter J. Bredenbeek, Richard Molenkamp, et al. · Virology · 125
PDF
A Live Attenuated Vaccine for Lassa Fever Made by Reassortment of Lassa and Mopeia Viruses
2005 · Igor S. Lukashevich, Jean Patterson, et al. · Journal of Virology · 156
Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus
2002 · Igor S. Lukashevich, Mahmoud Djavani, et al. · Journal of Medical Virology · 60
Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein
2000 · Mahmoud Djavani, Cheng Yin, et al. · Vaccine · 34
Lassa and mopeia virus replication in human monocytes/macrophages and in endothelial cells: Different effects on IL-8 and TNF-? gene expression
1999 · Igor S. Lukashevich, Raisa Maryankova, et al. · Journal of Medical Virology · 138